Transitioning subcutaneous immunoglobulin 20% therapies in patients with primary and secondary immunodeficiencies: Canadian real-world study

This study aimed to assess infusion parameters and experience of patients with primary (PID) or seco...

Source: Allergy, Asthma and Clinical Immunology - August 7, 2022 Category: Allergy & Immunology Authors: Paul K. Keith, Juthaporn Cowan, Amin Kanani, Harold Kim, Gina Lacuesta, Jason K. Lee, Jie Chen, Michelle Park and Andr é Gladiator Tags: Research Source Type: research